Cargando…

Inhibition of MNKs promotes macrophage immunosuppressive phenotype to limit CD8(+) T cell antitumor immunity

To elicit effective antitumor responses, CD8(+) T cells need to infiltrate tumors and sustain their effector function within the immunosuppressive tumor microenvironment (TME). Here, we evaluate the role of MNK activity in regulating CD8(+) T cell infiltration and antitumor activity in pancreatic an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pham, Thao N.D., Spaulding, Christina, Shields, Mario A., Metropulos, Anastasia E., Shah, Dhavan N., Khalafalla, Mahmoud G., Principe, Daniel R., Bentrem, David J., Munshi, Hidayatullah G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Clinical Investigation 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9090262/ https://www.ncbi.nlm.nih.gov/pubmed/35380995 http://dx.doi.org/10.1172/jci.insight.152731

Ejemplares similares

Gα13 loss in Kras/Tp53 mouse model of pancreatic tumorigenesis promotes tumors susceptible to rapamycin
por: Shields, Mario A., et al.
Publicado: (2022)

BET inhibition rescues ciliogenesis and ameliorates pancreatitis-driven phenotypic changes in mice with Par3 loss
por: Shields, Mario A., et al.
Publicado: (2023)

Quercetin Enhances the Anti-Tumor Effects of BET Inhibitors by Suppressing hnRNPA1
por: Pham, Thao N.D., et al.
Publicado: (2019)

Controlling TIME: How MNK Kinases Function to Shape Tumor Immunity
por: Pham, Thao N.D., et al.
Publicado: (2020)

The difficulty in translating the preclinical success of combined TGFβ and immune checkpoint inhibition to clinical trial
por: Metropulos, Anastasia E., et al.
Publicado: (2022)

Preclinical Models of Pancreatic Ductal Adenocarcinoma and Their Utility in Immunotherapy Studies
por: Pham, Thao N. D., et al.
Publicado: (2021)

Targeting Mnks for Cancer Therapy
por: Hou, Jinqiang, et al.
Publicado: (2012)

miR-134 increases the antitumor effects of cytarabine by targeting Mnks in acute myeloid leukemia cells
por: Chen, Kankan, et al.
Publicado: (2018)

Deeping in the Role of the MAP-Kinases Interacting Kinases (MNKs) in Cancer
por: Pinto-Díez, Celia, et al.
Publicado: (2020)

Contribution of Epithelial-Mesenchymal Transition to Pancreatic Cancer Progression
por: Krantz, Seth B., et al.
Publicado: (2010)

Interplay between interferon regulatory factor 1 and BRD4 in the regulation of PD-L1 in pancreatic stellate cells
por: Ebine, Kazumi, et al.
Publicado: (2018)

Environmental and genetic risk factors for gastric cancer
por: Shah, Dhavan, et al.
Publicado: (2022)

Intestinal adenocarcinoma originating from an undiagnosed Meckel’s diverticulum
por: Principe, Daniel R, et al.
Publicado: (2022)

Targeting BET Proteins Decreases Hyaluronidase-1 in Pancreatic Cancer
por: Kumar, Krishan, et al.
Publicado: (2023)

Regulatory T-Cells as an Emerging Barrier to Immune Checkpoint Inhibition in Lung Cancer
por: Principe, Daniel R., et al.
Publicado: (2021)

Alveolar soft part sarcoma mimics prostate cancer metastasis
por: Principe, Daniel R, et al.
Publicado: (2019)

MNKs act as a regulatory switch for eIF4E1 and eIF4E3 driven mRNA translation in DLBCL
por: Landon, Ari L., et al.
Publicado: (2014)

Calcium channel blockers potentiate gemcitabine chemotherapy in pancreatic cancer
por: Principe, Daniel R., et al.
Publicado: (2022)

Richard Hynes, Erkki Ruoslahti, and Timothy Springer receive Lasker prize for pioneering work on integrins
por: Munshi, Hidayatullah G.
Publicado: (2022)

Simultaneous targeting of androgen receptor (AR) and MAPK-interacting kinases (MNKs) by novel retinamides inhibits growth of human prostate cancer cell lines
por: Ramamurthy, Vidya P., et al.
Publicado: (2014)

The Current Treatment Paradigm for Pancreatic Ductal Adenocarcinoma and Barriers to Therapeutic Efficacy
por: Principe, Daniel R., et al.
Publicado: (2021)

GLI2-dependent c-MYC upregulation mediates resistance of pancreatic cancer cells to the BET bromodomain inhibitor JQ1
por: Kumar, Krishan, et al.
Publicado: (2015)

PEDF inhibits pancreatic tumorigenesis by attenuating the fibro-inflammatory reaction
por: Principe, Daniel R., et al.
Publicado: (2016)

Red-Light-Activatable AND-Gated Antitumor Immunosuppressant
por: Zhou, Ziqi, et al.
Publicado: (2023)

Loss of SMAD4 Is Associated With Poor Tumor Immunogenicity and Reduced PD-L1 Expression in Pancreatic Cancer
por: Principe, Daniel R., et al.
Publicado: (2022)

BET inhibitors in the treatment of hematologic malignancies: current insights and future prospects
por: Abedin, Sameem M, et al.
Publicado: (2016)

XP-524 is a dual-BET/EP300 inhibitor that represses oncogenic KRAS and potentiates immune checkpoint inhibition in pancreatic cancer
por: Principe, Daniel R., et al.
Publicado: (2022)

Targeting Immunosuppressive Tumor-Associated Macrophages Using Innate T Cells for Enhanced Antitumor Reactivity
por: Li, Yan-Ruide, et al.
Publicado: (2022)

First Mnks degrading agents block phosphorylation of eIF4E, induce apoptosis, inhibit cell growth, migration and invasion in triple negative and Her2-overexpressing breast cancer cell lines
por: Ramalingam, Senthilmurugan, et al.
Publicado: (2014)

Zileuton, 5-Lipoxygenase Inhibitor, Acts as a Chemopreventive Agent in Intestinal Polyposis, by Modulating Polyp and Systemic Inflammation
por: Gounaris, Elias, et al.
Publicado: (2015)

Reactive haemophagocytic lymphohistiocytosis: a frequent finding in immunosuppressed patients with multiple organ failure
por: Auzinger, G, et al.
Publicado: (2001)

CAR-T cell-mediated depletion of immunosuppressive tumor-associated macrophages promotes endogenous antitumor immunity and augments adoptive immunotherapy
por: Rodriguez-Garcia, Alba, et al.
Publicado: (2021)

Three-Dimensional Collagen I Promotes Gemcitabine Resistance In Vitro in Pancreatic Cancer Cells through HMGA2-Dependent Histone Acetyltransferase Expression
por: Dangi-Garimella, Surabhi, et al.
Publicado: (2013)

Comparative colloidal stability, antitumor efficacy, and immunosuppressive effect of commercial paclitaxel nanoformulations
por: Ye, Jun, et al.
Publicado: (2021)

Tertiary Lymphoid Structures in Cancer: Drivers of Antitumor Immunity, Immunosuppression, or Bystander Sentinels in Disease?
por: Colbeck, Emily Jayne, et al.
Publicado: (2017)

Injectable Hydrogel as a Unique Platform for Antitumor Therapy Targeting Immunosuppressive Tumor Microenvironment
por: Liu, Yushuai, et al.
Publicado: (2022)

Ursodeoxycholic acid reduces antitumor immunosuppression by inducing CHIP-mediated TGF-β degradation
por: Shen, Yingying, et al.
Publicado: (2022)

GTN Enhances Antitumor Effects of Doxorubicin in TNBC by Targeting the Immunosuppressive Activity of PMN-MDSC
por: Mabrouk, Nesrine, et al.
Publicado: (2023)

Dual oxidase 1 limits the IFNγ-associated antitumor effect of macrophages
por: Meziani, Lydia, et al.
Publicado: (2020)

Targeting BET bromodomain proteins in solid tumors
por: Sahai, Vaibhav, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_tec40fo9gr3okudp4to9br91c0